Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG II

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 6 56-6, 2004, Pages

  Lu, Ning ^a,b   Helwig, Bryan G ^a   Fels, Richard J ^a   Parimi, Sujatha ^a   Kenney, Michael J ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

4 hydroxy 2,2,6,6 tetramethylpiperidine 1 oxyl; Angiotensin II; Intracerebroventricular; Superoxide dismutase

Indexed keywords

ANGIOTENSIN; CHLORALOSE; LOSARTAN; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSORECEPTOR; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BRAIN; CYCLIC N-OXIDES; DRUG INTERACTIONS; HEART RATE; HEAT; INJECTIONS, INTRAVENTRICULAR; LOSARTAN; RATS; RATS, SPRAGUE-DAWLEY; SPIN LABELS; SUPEROXIDES; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTOR AGENTS;

EID: 9344252291     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00030.2004     Document Type: Article

References (54)

1. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281-R283, 2002.
2. 1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res 665: 245-252, 1994.
3. Budzikowski AS and Leenen FH. ANG II in median preoptic nucleus and pressor responses to CSF sodium and high sodium intake in SHR. Am J Physiol Heart Circ Physiol 281: H1210-H1216, 2001.
4. Campese VM, Ye S, and Zhong H. Downregulation of neuronal nitric oxide synthase and interleukin-1β mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 39: 519-524, 2002.
5. DiBona GF. Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 11: 197-200, 2002.
6. DiBona GF, Jones SY, and Brooks VL. ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol Regul Integr Comp Physiol 269: R1189-R1196, 1995.
7. DiBona GF, Sawin LL, and Jones SY. Characteristics of renal sympathetic nerve activity in sodium-retaining disorders. Am J Physiol Regul Integr Comp Physiol 271: R295-R302, 1996.
8. Ferguson DW, Berg WJ, and Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 16: 1125-1134, 1990.
9. 2: a pulse radiolysis study. Free Radic Biol Med 19: 505-510, 1995.
10. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
11. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, and Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105: 1656-1662, 2002.
12. Harada S, Tokunaga S, Momohara M, Masaki H, Tagawa T, Imaizumi T, and Takeshita A. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res 72: 511-516, 1993.
13. Harrison DG, Cai H, Landmesser U, and Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4: 51-61, 2003.
14. Hirai T, Musch TI, Morgan DA, Kregel KC, Claassen DE, Pickar JG, Lewis SJ, and Kenney MJ. Differential sympathetic nerve responses to nitric oxide synthase inhibition in anesthetized rats. Am J Physiol Regul Integr Comp Physiol 269: R807-R813, 1995.
15. Huang BS and Leenen FHH. Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake. Hypertension 32: 1028-1033, 1998.
16. Johnson AK and Thunhorst RL. The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol 18: 292-353, 1997.
17. Kenney MJ, Claassen DE, Bishop MR, and Fels RJ. Regulation of the sympathetic nerve discharge bursting pattern during heat stress. Am J Physiol Regul Integr Comp Physiol 275: R1992-R2001, 1998.
18. Kenney MJ and Fels RJ. Sympathetic nerve regulation to heating is altered in senescent rats. Am J Physiol Regul Integr Comp Physiol 283: R513-R520, 2002.
19. Kenney MJ and Fels RJ. Forebrain and brain stem neural circuits contribute to altered sympathetic responses to heating in senescent rats. J Appl Physiol 95: 1986-1993, 2003.
20. Kenney MJ, Musch TI, and Weiss ML. Renal sympathetic nerve regulation to heating is altered in rats with heart failure. Am J Physiol Heart Circ Physiol 280: H2868-H2875, 2001.
21. Kenney MJ, Weiss ML, Patel KP, Wang Y, and Fels RJ. Paraventricular nucleus bicuculline alters frequency components of sympathetic nerve discharge bursts. Am J Physiol Heart Circ Physiol 281: H1233-H1241, 2001.
22. Krieger EM. Neurogenic hypertension in the rat. Circ Res 15: 511-521, 1964.
23. Konsman JP, Tridon V, and Dantzer R. Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience 101: 957-967, 2000.
24. phox homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894, 2001.
25. Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, Sundlof G, and Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73: 913-919, 1986.
26. Liu JL, Murakami H, and Zucker IH. Angiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ Res 82: 496-502, 1998.
27. Liu JL and Zucker IH. Regulation of sympathetic nerve activity in heart failure: a role for nitric oxide and angiotensin II. Circ Res 84: 417-423, 1999.
28. Lu N, Wang Y, Blecha F, Fels RJ, Hoch HP, and Kenney MJ. Central interleukin-1β antibody increases renal and splenic sympathetic nerve discharge. Am J Physiol Heart Circ Physiol 284: H1536-H1541, 2003.
29. Maiorov DN, Wilton ER, Badoer E, Petrie D, Head GA, and Malpas SC. Sympathetic response to stimulation of the pontine A5 region in conscious rabbits. Brain Res 815: 227-236, 1999.
30. 2 receptors in the brain. Clin Exp Pharmacol Physiol Suppl 3: S99-S104, 1996.
31. Mollnau H, Wendt M, Szöcs K, Lassègue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleshyov AL, Tsilimingas N, Walter U, Förstermann U, Meinertz T, Griendling K, and Münzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: e58-e65, 2002.
32. Muders F, Riegger GA, Bahner U, and Palkovits M. The central vasopressinergic system in experimental left ventricular hypertrophy and dysfunction. Prog Brain Res 139: 275-279, 2002.
33. Ortiz MC, Manriquez MC, Romero JC, and Juncos LA. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension 38: 655-659, 2001.
34. Palatini P. Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease. Curr Hypertens Rep 3 Suppl 1: S3-S9, 2001.
35. 2-isoprostanes in rats. Hypertension 35: 476-479, 2000.
36. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol Endocrinol Metab 262: E763-E778, 1992.
37. - and systolic blood pressure in mice. Circ Res 89: 408-414, 2001.
38. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, and Ogawa S. ERK and p38 MAPK but not NF-κB are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89: 661-669, 2001.
39. Sasaki S and Dampney RA. Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension 15: 274-283, 1990.
40. Shapoval LN, Sagach VF, and Pobegailo LS. Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 132: 47-50, 1991.
41. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, and Abe Y. Renal sympathetic nerve responses to Tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
42. Tobey JC, Fry HK, Mizejewski CS, Fink GD, and Weaver LC. Differential sympathetic responses initiated by angiotensin and sodium chloride. Am J Physiol Regul Integr Comp Physiol 245: R60-R68, 1983.
43. Wenzel RR, Bruck H, Noll G, Schäfers RF, Daul AE, and Philipp T. Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol 35 Suppl 4: S43-S52, 2000.
44. Whitebread S, Mele M, Kamber B, and de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 163: 284-291, 1989.
45. Xu H, Fink GD, Chen A, Watts S, and Galligan JJ. Nitric oxide-independent effects of Tempol on sympathetic nerve activity and blood pressure in normotensive rats. Am J Physiol Heart Circ Physiol 281: H975-H980, 2001.
46. Xu H, Fink GD, and Galligan JJ. Nitric oxide-independent effects of Tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol 283: H885-H892, 2002.
47. - in DOCA-salt rats. Hypertension 43: 329-334, 2004.
48. Ye S, Zhong H, Duong VN, and Campese VM. Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 39: 1101-1106, 2002.
49. Zanzinger J and Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflügers Arch 439: 489-494, 2000.
50. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vasquez-Vivar J, and Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 34: 1359-1368, 2003.
51. Zhang W, Huang BS, and Leenen FHH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol Heart Circ Physiol 276: H1608-H1615, 1999.
52. Zhang Y, Jang R, Mori TA, Croft KD, Schyvens CG, McKenzie KUS, and Whitworth JA. The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat. J Hypertens 21: 1513-1518, 2003.
53. Zhu GQ, Patel KP, Zucker IH, and Wang W. Microinjection of ANG II into paraventricular nucleus enhances cardiac sympathetic afferent reflex in rats. Am J Physiol Heart Circ Physiol 282: H2039-H2045, 2002.
54. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, and Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91: 1038-1045, 2002.